Acadia Pharmaceuticals (ACAD) Cash from Investing Activities Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -114.28% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 826.39% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -674.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -166.24% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -122.45% |
| 10 | Acadia Pharmaceuticals | 3.69 Bn | 2.84 Bn | 243.27 Mn | 153.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 153.43% |
| Dec 31, 2025 | -145.74% |
| Sep 30, 2025 | 3.77% |
| Jun 30, 2025 | 22.95% |
| Mar 31, 2025 | -783.60% |
| Dec 31, 2024 | 35,301.73% |
| Sep 30, 2024 | -341.74% |
| Jun 30, 2024 | 71.08% |
| Mar 31, 2024 | -107.29% |
| Dec 31, 2023 | 98.04% |
| Sep 30, 2023 | 120.91% |
| Jun 30, 2023 | -248.20% |
| Mar 31, 2023 | 46.57% |
| Dec 31, 2022 | -124.81% |
| Sep 30, 2022 | 109.88% |
| Jun 30, 2022 | -224.27% |
| Mar 31, 2022 | 325.38% |
| Dec 31, 2021 | 161.17% |
| Sep 30, 2021 | -202.17% |
| Jun 30, 2021 | -113.56% |
| Mar 31, 2021 | 4.29% |
| Dec 31, 2020 | 44.08% |
| Sep 30, 2020 | 1,441.81% |
| Jun 30, 2020 | 1,093.80% |
| Mar 31, 2020 | 30.10% |
| Dec 31, 2019 | -10.69% |
| Sep 30, 2019 | -68.78% |
| Jun 30, 2019 | 369.58% |
| Mar 31, 2019 | -74.61% |
| Dec 31, 2018 | -944.32% |
| Sep 30, 2018 | 64.41% |
| Jun 30, 2018 | -110.29% |
| Mar 31, 2018 | 69.30% |
| Dec 31, 2017 | -126.17% |
| Sep 30, 2017 | 112.48% |
| Jun 30, 2017 | 613.39% |
| Mar 31, 2017 | 131.38% |
| Dec 31, 2016 | 21.89% |
| Sep 30, 2016 | -1,964.56% |
| Jun 30, 2016 | -116.93% |
| Mar 31, 2016 | -538.48% |
| Dec 31, 2015 | 40.14% |
| Sep 30, 2015 | -78.63% |
| Jun 30, 2015 | 165.27% |
| Mar 31, 2015 | 138.82% |
| Dec 31, 2014 | 324.23% |
| Sep 30, 2014 | 1,085.87% |
| Jun 30, 2014 | 31.54% |
| Mar 31, 2014 | -199.56% |
| Dec 31, 2013 | 127.22% |
| Sep 30, 2013 | -43.70% |
| Jun 30, 2013 | -1,274.98% |
| Mar 31, 2013 | -953.39% |
| Dec 31, 2012 | -1,018.85% |
| Sep 30, 2012 | -161.28% |
| Jun 30, 2012 | 30.69% |
| Mar 31, 2012 | 144.38% |
| Dec 31, 2011 | 149.16% |
| Sep 30, 2011 | 52.16% |